The Drug Enforcement Administration (DEA) has revealed in a new filing for the cannabis rescheduling hearing set to start on Monday that its witness list includes a doctor who will provide testimony about how “medical marijuana provides a medical benefit to pain patients.”
The government’s other witness is a Food and Drug Administration (FDA) official who will describe the process the agency used to develop a recommendation to transfer cannabis from Schedule I of the Controlled Substances Act (CSA) to Schedule III.
Corey Burchman, a medical doctor from New Hampshire, has been a practicing physician for more than 30 years and “will testify as a medical expert in the practice of pain management, with significant clinical experience in the use of medical marijuana,” DEA said in the new filing.
“Dr. Burchman will testify that he provided direct patient care for pain patients as an anesthesiologist and pain management physician following his residency and fellowship training in 1986 until 2019. He will testify that he was practicing at the Dartmouth-Hitchcock Medical Center in Hanover, NH when the medical center began prioritizing medical marijuana as a treatment modality for pain patients and he worked to transition many patients from treatment with opioids
Read full article on Marijuana Moment
